Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ · Healthcare
$40.06+1.14%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $2.62B
- P/E ratio
- —
- EPS
- —
- Volume
- 622,645
- 52-week high
- —
- 52-week low
- —
- Open
- $39.76
- Day high
- $40.50
- Day low
- $39.76
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $54.03M | -$412.78M | -$7.12 |
| 2024 | $36.5M | $673.73M | $11.64 |
| 2023 | $26.82M | -$352.09M | -$6.33 |
| 2022 | $14.24M | -$231.8M | -$4.23 |
| 2021 | $0 | $1.6B | $26.55 |
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to the research and advancement of new treatments, specifically targeting cellular metabolism and related biological fields. The company's offerings include PYRUKYND (mitapivat), a medication designed to activate both wild-type and various mutated pyruvate kinase (PK) enzymes, used in the management of hemolytic anemias. Additionally, Agios is developing AG-946, which is currently undergoing Phase I clinical studies for treating hemolytic anemias and other diseases. Established in 2007, the company's main office is located in Cambridge, Massachusetts.
- CEO
- Brian Goff
- Employees
- 486
- Country
- US
- IPO date
- Jul 24, 2013
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Agios Pharmaceuticals, Inc.'s stock price today?
- AGIO is trading at $40.06 as of Jul 20, 2026.
- What is Agios Pharmaceuticals, Inc.'s market cap?
- Agios Pharmaceuticals, Inc. (AGIO) has a market capitalization of $2.62B.
- Does Agios Pharmaceuticals, Inc. pay a dividend?
- Agios Pharmaceuticals, Inc. did not pay a dividend in its most recent reported fiscal year.
- What sector is Agios Pharmaceuticals, Inc. in?
- Agios Pharmaceuticals, Inc. operates in the Healthcare sector.